Iga Lipska, MD PhD MPH

Deputy Director of the Clinical Research Support Centre, Medical University of Gdańsk

Former Research Consortium & Project Manager, Strategic research grant “The implementation of Hospital-based HTA (HB-HTA) in Poland” & Head of Health Care Services Monitoring Department, National Health Fund HQ (public payer), Warsaw, Poland
Co-author of Polish National Medicines Policy for 2018-2022 – governmental strategic document.
Former Director of Drug Policy and Pharmacy Department at Ministry of Health, former Economic Committee Member at Ministry of Health.
Former Director of HTA Department at Polish HTA Agency
She’s a medical doctor by education with master degree in public health.
She graduated from the University of Utrecht in the Netherlands, where she defended her PhD thesis on health technology assessment of new medicines.
Iga Lipska has broad international and Polish experience in the healthcare sector, with a main focus in recent years on HTA, drug pricing, health insurance, public health and evidence-based decision making process in health care.
Dr Lipska is an Advisory Board member of HTx project at Utrecht University and Core Member of Get Real Initiative Think Tank.
She is also a member of International Scientific Committee for Health Technology Assessment international Annual Meeting in Utrecht in 2022.
She has been co-chairing International Society for Pharmacoeconomics and Outcomes research (ISPOR) HTA Roundtable Europe for 3 years’ term (from 2019 to 2022).
Starting June 2022 she has been co-chairing HB-HTA Interest Group at Health Technology Assessment international (influential global organization) for 3 years’ term.

_________

Paweł Sudara photographer